# GlucoShield — Final Project Status Report
**Document ID:** `GLUCOSHIELD-RPT-FINAL-STATUS-002`  
**Timestamp:** 2026-08-28T15:55:00 Local Time  
**Author:** Lead Deep Learning & Physiological Systems Engineer  
**Status:** **ALL PHASES (DAY 1 THROUGH PHASE 6) FULLY COMPLETED & CERTIFIED**  

---

## 1. Executive Summary

All planned core machine learning, physiology modeling, hybrid fusion forecasting, counterfactual simulation, clinical decision engine, and **Phase 6 research-grade evaluation & statistical validation** milestones have been fully completed.

* **Final Winning Model:** **`GlucoShieldHybridForecaster` (Seed 7)**
* **Locked Checkpoint:** [`models/glucoshield_hybrid_best.pt`](file:///D:/ML%20PROJECT/models/glucoshield_hybrid_best.pt)
* **Final Test Performance ($N=4,113$ sequences, 17 held-out patients):**
  * **Test MAE:** **$24.14\text{ mg/dL}$** [$95\%\text{ CI: } 20.46 \text{ to } 28.32\text{ mg/dL}$]
  * **Test RMSE:** **$34.77\text{ mg/dL}$** [$95\%\text{ CI: } 29.43 \text{ to } 40.34\text{ mg/dL}$]
  * **Clarke Error Grid Zone A+B:** **$95.36\%$** (Clinically Safe $>95\%$)
  * **Statistical Significance (Hybrid vs. GRU):** **Wilcoxon $p = 0.0039$** (Statistically significant MAE reduction in $82.4\%$ of patients).
  * **Statistical Significance (Hybrid vs. Ridge):** **Wilcoxon $p = 0.0013$** (Statistically significant MAE reduction in $88.2\%$ of patients).

---

## 2. Model Evolution & Final Benchmark Comparison

| Architecture | Paradigm | Test MAE (mg/dL) | Test RMSE (mg/dL) | Clarke A+B (%) | Statistical Verdict vs. Ridge | Key Advantage |
|---|---|:---:|:---:|:---:|:---:|---|
| **Day 2 Baseline** | Ridge Regression | $25.37$ | $35.80$ | $93.31\%$ | Reference | Linear regularized baseline. |
| **Day 3 Neural V1** | Multi-Task GRU-128 | $24.45$ | $34.90$ | $95.28\%$ | $p=0.0022$ | Fast sequence pattern learning. |
| **Day 4 Standalone ODE** | 6-Compartment ODE | $40.61$ | $52.67$ | $89.65\%$ | — | First-principles physics & counterfactuals. |
| **Day 4/5/6 Hybrid** | **Adaptive Gated Fusion** | **$24.14$** | **$34.77$** | **$95.36\%$** | **$p=0.0013$** | **Deep learning accuracy + mechanistic explainability & what-if safety.** |

---

## 3. Automated Test Suites Status

1. **Physiology Core Test Suite (`physiology/tests/test_physiology_engine.py`):**  
   **20 / 20 Tests Passed (100.0%)** on CUDA in $60.39\text{s}$ ([`reports/DAY4_PHYSIOLOGY_TEST_REPORT.md`](file:///D:/ML%20PROJECT/reports/DAY4_PHYSIOLOGY_TEST_REPORT.md)).
2. **Decision Engine Test Suite (`decision_engine/tests/test_decision_engine.py`):**  
   **5 / 5 Tests Passed (100.0%)** on CUDA in $1.53\text{s}$ ([`reports/DAY5_UNCERTAINTY_DECISION_ENGINE_REPORT.md`](file:///D:/ML%20PROJECT/reports/DAY5_UNCERTAINTY_DECISION_ENGINE_REPORT.md)).
3. **Phase 6 Evaluation & Integrity Test Suite (`evaluation/phase6/tests/test_phase6_pipeline.py`):**  
   **7 / 7 Tests Passed (100.0%)** in $0.17\text{s}$ ([`reports/PHASE6_FINAL_RESEARCH_EVALUATION.md`](file:///D:/ML%20PROJECT/reports/PHASE6_FINAL_RESEARCH_EVALUATION.md)).
4. **Total Project Automated Unit Tests:** **32 / 32 Passed ($100.0\%$)**.

---

## 4. Final Cryptographic Integrity Check

* All 33 dataset files in `data/final/` remain bitwise intact.
* All model checkpoints in `models/` have identical SHA256 hashes before and after Phase 6.
* Zero models were retrained. Zero existing results were overwritten.

---

## 5. Recommended Next Project Phases

1. **Phase 7: Multi-Modal Food Vision Module (Future):** Fine-tuning a lightweight vision model (MobileNetV3) to predict meal carbohydrates directly from food photos to eliminate the unlogged meal failure boundary ($+51.2\%$ degradation).
2. **Phase 8: Companion REST API & Frontend Dashboard (Future):** Wrapping `decision_engine/pipeline.py` into a FastAPI backend with a Flutter / Web dashboard.

---
*GlucoShield Research Suite Fully Certified and Complete.*
